Evidence map›Paper›PMID 24682362›Full record

ArticleThe Journal of biological chemistry2014

Groove-type recognition of chlamydiaceae-specific lipopolysaccharide antigen by a family of antibodies possessing an unusual variable heavy chain N-linked glycan.

Omid Haji-Ghassemi, Sven Müller-Loennies, Radka Saldova, Mohankumar Muniyappa, Lore Brade, Pauline M Rudd, David J Harvey, Paul Kosma, Helmut Brade, Stephen V Evans

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 5 countries.

Omid Haji-GhassemiFrom the Department of Biochemistry and Microbiology, University of Victoria, Victoria, British Columbia V8P 3P6, Canada.
Sven Müller-LoenniesResearch Center Borstel, Leibniz-Center for Medicine and Biosciences, Parkallee 22, Borstel D-23845, Germany, sml@fz-borstel.de.
Radka SaldovaGlycoScience Group, the National Institute for Bioprocessing Research and Training (NIBRT), Mount Merrion, Blackrock, Dublin 4, Ireland.
Mohankumar MuniyappaGlycoScience Group, the National Institute for Bioprocessing Research and Training (NIBRT), Mount Merrion, Blackrock, Dublin 4, Ireland.
Lore BradeResearch Center Borstel, Leibniz-Center for Medicine and Biosciences, Parkallee 22, Borstel D-23845, Germany.
Pauline M RuddGlycoScience Group, the National Institute for Bioprocessing Research and Training (NIBRT), Mount Merrion, Blackrock, Dublin 4, Ireland.
David J HarveyOxford Glycobiology Institute, Department of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, United Kingdom.
Paul KosmaUniversity of Natural Resources and Life Sciences, Vienna, Austria, and.
Helmut BradeResearch Center Borstel, Leibniz-Center for Medicine and Biosciences, Parkallee 22, Borstel D-23845, Germany.
Stephen V EvansFrom the Department of Biochemistry and Microbiology, University of Victoria, Victoria, British Columbia V8P 3P6, Canada, svevans@uvic.ca.
National Institute for Bioprocessing Research and Training · IEResearch Center Borstel - Leibniz Lung Center · DEUniversity of Victoria · CABOKU University · ATUniversity of Oxford · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The structure of the antigen binding fragment of mAb S25-26, determined to 1.95 Å resolution in complex with the Chlamydiaceae family-specific trisaccharide antigen Kdo(2→8)Kdo(2→4)Kdo (Kdo = 3-deoxy-α-d-manno-oct-2-ulopyranosonic acid), displays a germ-line-coded paratope that differs significantly from previously characterized Chlamydiaceae-specific mAbs despite being raised against the identical immunogen. Unlike the terminal Kdo recognition pocket that promotes cross-reactivity in S25-2-type antibodies, S25-26 and the closely related S25-23 utilize a groove composed of germ-line residues to recognize the entire trisaccharide antigen and so confer strict specificity. Interest in S25-23 was sparked by its rare high μm affinity and strict specificity for the family-specific trisaccharide antigen; however, only the related antibody S25-26 proved amenable to crystallization. The structures of three unliganded forms of S25-26 have a labile complementary-determining region H3 adjacent to significant glycosylation of the variable heavy chain on asparagine 85 in Framework Region 3. Analysis of the glycan reveals a heterogeneous mixture with a common root structure that contains an unusually high number of terminal αGal-Gal moieties. One of the few reported structures of glycosylated mAbs containing these epitopes is the therapeutic antibody Cetuximab; however, unlike Cetuximab, one of the unliganded structures in S25-26 shows significant order in the glycan with appropriate electron density for nine residues. The elucidation of the three-dimensional structure of an αGal-containing N-linked glycan on a mAb variable heavy chain has potential clinical interest, as it has been implicated in allergic response in patients receiving therapeutic antibodies.

Indexed as

Binding Sites, AntibodyAmino Acid SequenceAntibodies, BacterialAntibody AffinityChlamydiaImmunoglobulin Heavy ChainsImmunoglobulin Variable RegionLipopolysaccharidesMolecular Docking SimulationMolecular Sequence DataAntibodies, BacterialImmunoglobulin Heavy ChainsImmunoglobulin Variable RegionLipopolysaccharidesAntibodiesAntigenCarbohydrate ComplexGlycosylationX-ray Crystallography

Identifiers

PMID24682362
PMCPMC4059111
OpenAlexW2064871574

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.